Advances in treatment of myocardial infarction by mesenchymal stem cell transplantation / 生物医学工程学杂志
Journal of Biomedical Engineering
;
(6): 939-944, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-234480
ABSTRACT
Mesenchymal stem cells(MSCs)is a kind of non hematopoietic stem cell from the mesoderm, which can self renew, proliferate and perform multilineage differentiation. Due to the characteristics of acquiring easily and low immunogenicity, it has become the main cell for myocardial infarction. In this article, the biology and the immunology of the MSCs is reviewed, the safety and the validity of the therapy on myocardial infarction with MSCs and the HGF/MSCs is introduced. And furthermore, it also explains the possible mechanism and the problems of how to improve the cardial function.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Therapeutics
/
Hematopoietic Stem Cells
/
Cell Differentiation
/
Mesenchymal Stem Cell Transplantation
/
Mesenchymal Stem Cells
/
Myocardial Infarction
Limits:
Humans
Language:
Chinese
Journal:
Journal of Biomedical Engineering
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS